Robeco Institutional Asset Management
RGNX icon

Robeco Institutional Asset Management’s Regenxbio RGNX Stock Holding History

Robeco Institutional Asset Management’s Portfolio RGNX Stock Details RGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,525
Closed -$47.7K – 1089
2023
Q1 		$47.7K Buy
+2,525
New +$55.9K ﹤0.01% 1015

Other funds holding RGNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
ACM
Aquilo Capital Management San Francisco, California $55.8M AUM 41.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
WM
WS Management Jacksonville, Florida $1.14B AUM 139.27% 1-Year Est. Return
SGL
Sonic GP LLC Honolulu, Hawaii $45.4M AUM 5.08% 1-Year Est. Return

Robeco Institutional Asset Management's RGNX Position: Q2 2023 in Review

Robeco Institutional Asset Management sold out of Regenxbio (RGNX) in Q2 2023, closing a stake of 2,525 shares — an estimated $47.7K sold.

Robeco Institutional Asset Management first reported a position in RGNX in Q1 2023 and held it in 1 quarter. The position peaked at $47.7K in Q1 2023. 166 funds tracked by Wall St. Rank hold RGNX as of Q2 2023.

  • Robeco Institutional Asset Management reported no remaining Regenxbio position as of Q2 2023 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 2,525 Regenxbio shares in Q2 2023, an estimated $47.7K.
  • Robeco Institutional Asset Management first reported a position in Regenxbio in Q1 2023 and held it in 1 quarter.
  • Robeco Institutional Asset Management's Regenxbio position peaked at $47.7K in Q1 2023.
  • 166 funds tracked by Wall St. Rank held Regenxbio as of Q2 2023.

Based on Robeco Institutional Asset Management's 13F filing for Q2 2023, filed 24 Jul 2023.